The Global Melphalan Market Report is a compilation of comprehensive research studies of various aspects of the Melphalan Market. With accurate data and highly authentic information, a brilliant attempt is made to paint a true, transparent picture of the current and future situations of the global Melphalan market. Market participants can use this powerful tool when creating effective business plans or making major changes to their strategies. The report discusses the growth of the global as well as regional markets. It also throws light on high-growth segments of the global Melphalan market and how they will evolve in the years to come.
Request a PDF sample copy of this report at @ https://www.absolutemarketsinsights.com/request_sample.php?id=721
United States Melphalan market was valued at US$ 137.85 million in 2022 and is expected to reach US$ 203.73 million by 2030, growing at a CAGR of 4.4% over the forecast period. Key Players: Acrotech Biopharma, LLC., ApoPharma Inc., CELGENE CORPORATION, Fresenius Kabi USA, LLC, Ingenus Pharmaceuticals, LLC, and Mylan Inc. amongst others.
Melphalan is a chemotherapy medication and is often referred to as Alkeran. The drug is used for treatment of various type of cancers like multiple myeloma, breast cancer, and ovarian cancer amongst others. Melphalan is one of a group of medicines called alkylating agents; it binds to one of the DNA strands of a cancer cell. The genetic code that is in the nucleus of all cells in animals and plants is DNA. The drug controls everything the cell does and helps in eliminating the cell growth and the then it is then unlikely for the cell to expand and break into 2 new cells.
Melphalan is a medication which can be given as an injection through a vein and is also available in tablet form. The drug comes as a white tablet which is taken while the stomach is empty and the tablets needs to be stored in a cool place. The duration of therapy depends on the types of medications patients take, how well the body reacts to them, and the type of cancer the patient is having. The drug is majorly used for cancer treatment but the physicians also prescribe the drug for treatment of other diseases. The amount of drug to be prescribed depends on various factors such as height and weight of the patient and also considers general health problems of the patient. Presently Melphalan is available in the United States market in the form of capsules as well as injection. There are many suppliers as well as distributors currently active in the market. The Melphalan drug manufacturing companies are striving to maintain a steady supply of the drug in the market. As it is on the list of essential drugs a steady flow of the drug is being maintained in the market for the patients suffering from cancer.
Another factor which will boost the growth of Melphalan market is the increasing number of cancer patients in United States. Cancer has a very serious impact in the United States, more than 1.8 million new cases are being registered in the country and the number is increasing at a very high rate. Most common cancers in United States are prostate cancer, lung cancer, breast cancer and pancreatic cancer amongst others. In order to reduce the mortality rate amongst cancer patients the government is undertaking many initiatives and is investing more on the R&D projects associated with finding cure to cancer. Government spending on cancer treatment and supplying of advanced medication has increased over the years. 1 out of 6 deaths in United States is due to cancer this will boost the demand for Melphalan drugs in the market. In order to reduce the death rate of patients diagnosed with cancer the services are getting people centred and the demand for effective medication to treat cancer is increasing. Melphalan manufacturers and suppliers are keeping constant supply of the drug in the market. As the drug is used to treat several types of cancer like ovarian cancer, multiple myeloma and breast cancer will fuel the demand for the Melphalan drug over the forecast period.
Melphalan is used in various preparations and is promoted in numerous brand names. The number of patients diagnosed with multiple myeloma is rising day by day. The number of patients with multiple myeloma has increased rapidly in United States over the years. Considering the year 2020 there are more than 32000 cases recorded for multiple myeloma in United States and it is expected that more than 12000 deaths will occur due to this. Multiple myeloma is the most common blood cancer in United States and the overall death rate due to multiple myeloma has risen over the years. Melphalan is used majorly for the treatment of multiple myeloma aiding in increasing the life expectancy of the patients this factor will boost the adoption of Melphalan for the treatment of multiple myeloma over the forecast period. Melphalan is an alkylating agent which attaches the chemical molecules to DNA, Melphalan reduces the rapidly dividing myeloma cells from replicating and helps in controlling cell duplication.
For myeloma high doses of Melphalan are administered and this high dosage is more effective in reducing the myeloma cells. Melphalan along with Autologous stem-cell transplantation (ASCT) has yielded better outcomes than the traditional chemotherapy medication. 65 years old or younger patients have shown promising results for the treatment thus boosting the adoption of the drug in the years to come. The overall rate of survival for patients with multiple myeloma is 74% and if the cancer is spread to other parts then the survival rate gets decreased to 51%. Due to advancement in chemotherapy medication the overall survival rate has increased in the United States over the years. Government initiative towards reducing the number of deaths in cancer patients and advanced medication for treatment of cancer is propelling the growth of Melphalan market over the forecast period.
However the drug has many side effects like allergic reaction, mouth sores, diarrhea, and hair loss amongst others. Also using Melphalan the patient can develop infection more easily and that infection can be serious leading to death. This could hamper the growth of Melphalan market over the forecast period. By taking this drug there is a slight chance of developing blood cancer such as leukemia also the major side effect that occurs is low blood count among patients, these factors could refrain the growth of the market over the forecast period. However the effects of the drug are reversible and are likely to go away when the medication is complete, the healthcare professionals constantly monitor the patients administered with Melphalan. In order to prevent side effects in patients the professionals continuously check the response of patients to the therapy. The drug is being used in many experiments related to cancer and is showing promising results. Melphalan can be used as an anti-cancer drug by giving high dosage to the patients for treatment of solid tumor malignancies. Due to efficient results of the drug for treatment of various cancer and efficient outcomes are increasing the demand for Melphalan over the forecast period.
Purchase the latest in-depth Market Report @ https://www.absolutemarketsinsights.com/checkout?id=721
- By Dosage
- Tablet, Film Coated
- Injection Powder, lyophilized, for Solution
- By Route
- Oral (2 mg/1, 2MG, 5MG)
- Intra-arterial, Intravenous 50 mg/10 ml
- By Indication
- Multiple Myeloma
- Ovarian Cancer
- Breast Cancer
- Used in some Conditioning Regimens Prior to Bone Marrow Transplant
- Non-resectable Epithelial Carcinoma of the Ovary
- Recurrent or Unresectable in-transit Metastatic Melanoma
- Treatment of Amyloidosis with Prednisone
- Adjunct to Surgery in the Treatment of Breast Cancer
- Others (Severe Hodgkin Lymphoma, etc.)
- By Region
Besides target market information, Absolute Markets Insights also provides information about your competitor, your customers, products etc. A few techniques we use are:
- Customer analysis
- Competitor analysis
- Risk analysis
- Product research
- Advertising research
- E-mail survey and many more…
- Market Research Methodology
We define the research problem: The step defining the research problem exists of two main steps:
- Formulating the problem
- Establishing research objectives
- Selecting and Establishing Research Design
The step selecting and establishing research design consists of three main steps:
- Select the research design
- Identify information types and sources
- Determine and design research instrument
Read Detailed Index of full Research Study @ https://www.absolutemarketsinsights.com/reports/Melphalan-Market-2020—2028-721
Browse more trending reports by Absolute Markets Insights:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213